Peter P. Youssef

5.1k citations
100 papers · 4.2k · 3 hit papers · h-index 34

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Osteoarthritis Treatment and Mechanisms
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research
    • Systemic Sclerosis and Related Diseases

Papers in

    • Rheumatoid Arthritis Research and Therapies 32
    • Systemic Lupus Erythematosus Research 9
    • Spondyloarthritis Studies and Treatments 7
    • Systemic Sclerosis and Related Diseases 18

Peter P. Youssef

97 papers receiving 4.1k citations

Peter P. Youssef's Hit Papers

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study 2022 · 156 citations
1560+3+6Years since publication100200300400

Peers

Peter P. Youssef
Comparison fields: 5 of 106
  • Rheumatology 1.7k
  • Pathology and Forensic Medicine 780
  • Immunology 694
  • Pulmonary and Respiratory Medicine 845
  • Hematology 280
Replace Shin‐ya Kawashiri with:
Shin‐ya Kawashiri Japan
Ingo Helmut Tarner Germany
Mami Tamai Japan
Matija Tomšič Slovenia
Emese Virág Kiss Hungary
Gurtej S. Cheema United States
Tomoki Origuchi Japan
Kazuhiro Kurasawa Japan
Kunihiro Ichinose Japan
Aroldo Gabriele Rizzo Italy
Peter P. Youssef relative to Shin‐ya Kawashiri Japan Shin‐ya Kawashiri's profile →
Citations per field
00.5×2×2.6×
Shin‐ya Kawashiri · 1×
Citations per year

Countries citing papers authored by Peter P. Youssef

Since Specialization
Citations

This map shows the geographic impact of Peter P. Youssef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Youssef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Youssef more than expected).

Fields of papers citing papers by Peter P. Youssef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Youssef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Youssef. The network helps show where Peter P. Youssef may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter P. Youssef, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter P. Youssef Line = papers co-authored together Peter P. Youssef links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis.
1997463
2
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Hit paper breakdown →
2017412
3
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
Hit paper breakdown →
2017336
4 2001217
5
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Hit paper breakdown →
2022156
6 2012156
7
Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane.
1999122
8 2019106
9 1998106
10 2001105
11 2015101
12 199799
13 201296
14 200595
15
Limited scleroderma is associated with increased prevalence of macrovascular disease.
199578
16 199869
17
Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
201566
18 200163
19 201761
20 201961

About Peter P. Youssef

Peter P. Youssef is a scholar working on Rheumatology, Pathology and Forensic Medicine, Immunology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 100 papers that have together received 4.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (32 papers), Systemic Sclerosis and Related Diseases (18 papers), Systemic Lupus Erythematosus Research (9 papers), Spondyloarthritis Studies and Treatments (7 papers), Immune Response and Inflammation (5 papers), Pulmonary Hypertension Research and Treatments (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Rheumatology (1.7k citations), Pathology and Forensic Medicine (780 citations), Immunology (694 citations), Pulmonary and Respiratory Medicine (845 citations) and Hematology (280 citations). Peter P. Youssef has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Malcolm Anders Smith, Angela N. Parker, Michael Coleman, Barry Bresnihan, Peter J. Roberts-Thomson, Michael J Ahern, Oliver FitzGerald, Joanne Sahhar, Carolyn L. Geczy and Jim V. Bertouch. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Arthritis & Rheumatology and Clinical Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact